4DMedical Limited (ASX:4DX)

Australia flag Australia · Delayed Price · Currency is AUD
0.2500
-0.0050 (-1.96%)
Apr 4, 2025, 4:10 PM AEST
-60.00%
Market Cap 108.89M
Revenue (ttm) 5.86M
Net Income (ttm) -39.54M
Shares Out 427.03M
EPS (ttm) -0.09
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,009,407
Average Volume 1,214,560
Open 0.2500
Previous Close 0.2550
Day's Range 0.2450 - 0.2600
52-Week Range 0.2450 - 0.7150
Beta 1.36
RSI 26.11
Earnings Date May 28, 2025

About 4DMedical

4DMedical Limited operates as a medical technology company in the United States and Australia. It engages in the medical research technology and development of a non‑invasive respiratory imaging solution using four‑dimensional imaging. The company also offers X-ray velocimetry lung ventilation analysis software (XV LVAS), a lung airflow imaging software, that provides lung health detail from X-Ray scans; computed tomography lung ventilation analysis software (CT LVAS), an image processing software which operates on CT scans to provide functiona... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2012
Employees 145
Stock Exchange Australian Securities Exchange
Ticker Symbol 4DX
Full Company Profile

Financial Performance

In 2024, 4DMedical's revenue was 3.75 million, an increase of 422.45% compared to the previous year's 718,581. Losses were -35.98 million, 14.4% more than in 2023.

Financial Statements

News

There is no news available yet.